Watch Ticker

Ocugen, Inc. Common Stock

Go to Ocugen, Inc. Common Stock Website

$0.97

-0.03 (-3.09%)

Live

Previous Close

$0.955

Day Range

$0.95 - $1.01

Previous Day Range

$0.9659 - $1.02

Market Cap

$292.0 million USD

Day Vol.

3.3 million

Previous Day Vol.

2.4 million

Currency

USD

Primary Exchange

Nasdaq

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, No...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - AAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

A comprehensive analysis reveals over 70 companies developing AAV gene therapies for hereditary retinal diseases, offering potential transformative treatments for vision restoration through advanced gene therapy techniques.

Related tickers: NVS, JNJ, OCGN, MGTX.

Read Full Article

Henry Khederian - Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

Ocugen's shares are trading lower after the company announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics in an all-stock deal.

Related tickers: OCGN, CARM.

Read Full Article

Trending Tickers

Please sign in to view